146 related articles for article (PubMed ID: 24777261)
1. UV-independent p53 mutations in sebaceous carcinoma of the eyelid.
Hussain RM; Matthews JL; Dubovy SR; Thompson JM; Wang G
Ophthalmic Plast Reconstr Surg; 2014; 30(5):392-5. PubMed ID: 24777261
[TBL] [Abstract][Full Text] [Related]
2. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis.
Xu S; Moss TJ; Laura Rubin M; Ning J; Eterovic K; Yu H; Jia R; Fan X; Tetzlaff MT; Esmaeli B
Mod Pathol; 2020 Jul; 33(7):1256-1263. PubMed ID: 31937901
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
[TBL] [Abstract][Full Text] [Related]
6. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
[TBL] [Abstract][Full Text] [Related]
7. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53.
Gonzalez-Fernandez F; Kaltreider SA; Patnaik BD; Retief JD; Bao Y; Newman S; Stoler MH; Levine PA
Ophthalmology; 1998 Mar; 105(3):497-506. PubMed ID: 9499782
[TBL] [Abstract][Full Text] [Related]
8. Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid.
Hayashi N; Furihata M; Ohtsuki Y; Ueno H
Virchows Arch; 1994; 424(5):503-9. PubMed ID: 8032531
[TBL] [Abstract][Full Text] [Related]
9. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
[TBL] [Abstract][Full Text] [Related]
11. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
12. Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Bakhshi S; Pushker N; Sharma A; Kashyap S; Bajaj MS; Singh VK
Br J Ophthalmol; 2020 Jun; 104(6):879-884. PubMed ID: 30940620
[TBL] [Abstract][Full Text] [Related]
13. Outcome of periocular sebaceous gland carcinoma.
Burns SJ; Foss AJ; Butler TK
Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):353-5. PubMed ID: 16234697
[TBL] [Abstract][Full Text] [Related]
14. p53 staining correlates with tumor type and location in sebaceous neoplasms.
Shalin SC; Sakharpe A; Lyle S; Lev D; Calonje E; Lazar AJ
Am J Dermatopathol; 2012 Apr; 34(2):129-35; quiz 136-8. PubMed ID: 22441365
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
[TBL] [Abstract][Full Text] [Related]
16. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
[TBL] [Abstract][Full Text] [Related]
17. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.
Gu X; Huang Z; Chen J; Luo Y; Ge S; Jia R; Song X; Chai P; Xu S; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):16. PubMed ID: 38095907
[TBL] [Abstract][Full Text] [Related]
18. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma.
Shields CL; Naseripour M; Shields JA; Eagle RC
Ophthalmology; 2002 Nov; 109(11):2129-33. PubMed ID: 12414427
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.
Chao AN; Shields CL; Krema H; Shields JA
Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
